Biological activities of optimized biosynthesized selenium nanoparticles using Proteus mirabilis PQ350419 alone or combined with chitosan and ampicillin against common multidrug-resistant bacteria

Jul 5, 2025Microbial cell factories

Antibacterial effects of selenium nanoparticles made with Proteus mirabilis, alone or combined with chitosan and ampicillin, against common drug-resistant bacteria

AI simplified

Abstract

Selenium nanoparticles combined with chitosan and ampicillin demonstrated superior antibacterial activity with values of 30 to 100 µg/ml against several bacterial strains.

  • Selenium nanoparticles (Se NPs) were synthesized using the Proteus mirabilis strain PQ350419 as a bio-nano-factory.
  • The combination of Se NPs, chitosan, and ampicillin (Se/CS/AMP) showed enhanced antibacterial effectiveness compared to Se NPs and ampicillin alone.
  • Se/CS/AMP was effective in preventing formation by up to 50% in certain bacterial strains.
  • The synthesized nanocomposite exhibited a strong negative surface charge, which may contribute to its stability.
  • tests indicated that Se NPs and the Se/CS/AMP nanocomposite had a reduced impact on Vero cells, suggesting relative safety.

AI simplified

Key numbers

30 µg/ml
of Se/CS/AMP
values for Bacillus cereus and Staphylococcus aureus.
40.95 ± 2.34 µg/ml
CC of Se NPs
test results for Se NPs against Vero cells.
199.09 ± 2.61 µg/ml
CC of Se/CS/AMP
test results for Se/CS/AMP against Vero cells.

Full Text

What this is

  • This research focuses on the biosynthesis of selenium nanoparticles (Se NPs) using the bacterium Proteus mirabilis PQ350419.
  • It explores the combination of Se NPs with chitosan and ampicillin to enhance antibacterial and antibiofilm properties.
  • The study demonstrates the effectiveness of the Se/CS/AMP nanocomposite against multidrug-resistant bacteria, providing a potential alternative to traditional antibiotics.

Essence

  • Se/CS/AMP nanocomposite exhibits potent antibacterial activity against multidrug-resistant bacteria, outperforming Se NPs and ampicillin alone. The study emphasizes the safety and efficacy of this novel treatment.

Key takeaways

  • Se/CS/AMP demonstrated lower minimum inhibitory concentrations (MICs) compared to Se NPs alone, indicating enhanced antibacterial efficacy. The values for Se/CS/AMP were 30 µg/ml, 40 µg/ml, 60 µg/ml, and 100 µg/ml against various bacterial strains.
  • The nanocomposite significantly inhibited formation by up to 50% in Staphylococcus aureus, Klebsiella pneumoniae, and Proteus mirabilis. This suggests potential applications in preventing -related infections.
  • tests revealed that Se NPs had a CC of 40.95 ± 2.34 µg/ml, while Se/CS/AMP had a CC of 199.09 ± 2.61 µg/ml, indicating a safer profile for the nanocomposite.

Caveats

  • The study primarily focuses on in vitro results; further in vivo studies are needed to confirm the effectiveness and safety of Se/CS/AMP in clinical settings.
  • While the antibacterial properties are promising, the potential for bacterial resistance to Se NPs and the nanocomposite warrants ongoing investigation.

Definitions

  • Minimum Inhibitory Concentration (MIC): The lowest concentration of an antimicrobial agent that prevents visible growth of a microorganism.
  • Cytotoxicity: The quality of being toxic to cells, often assessed to evaluate the safety of substances.
  • Biofilm: A structured community of microbial cells embedded in a self-produced polymeric matrix attached to a surface.

AI simplified

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free